ORIFARM A/S — Credit Rating and Financial Key Figures

ORIFARM A/S (CVR number: 26058708) is a company from ODENSE. The company reported a net sales of 1223.8 mDKK in 2024, demonstrating a decline of -22.3 % compared to the previous year. The operating profit percentage was at 1.2 % (EBIT: 15.3 mDKK), while net earnings were 14.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 8.6 %, which can be considered good but Return on Equity (ROE) was 22.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 35.9 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM A/S's liquidity measured by quick ratio was 1.5 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.